Clin Endosc.  2024 Jul;57(4):466-467. 10.5946/ce.2024.033.

Is your endoscopist qualified enough to detect Helicobacter pylori-naive status?

• Lee SY

• KMID: 2558100
• DOI: http://doi.org/10.5946/ce.2024.033

Reference

1. Lee SY, Nakajima S. Current status of endoscopic gastric cancer screening in South Korea. J Gastrointestinal Cancer Screen. 2023; 61:292–306.

2. Ono S, Kato M. What is the definition of Helicobacter pylori-negative gastric cancer? Comment on: Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter. 2012; 17:238.

3. Imamura K, Yao K, Nimura S, et al. Clinicopathological and endoscopic features of Helicobacter pylori infection-negative gastric cancer in Japan: a retrospective study. Clin Endosc. 2024; 57:486–494.

4. Kotani S, Shibagaki K, Hirahara N, et al. Clinicopathologic differences of gastric neoplasms between Helicobacter pylori-infected and -naïve patients: a multicenter retrospective analysis. J Gastroenterol. 2024; 59:1–10.

5. Na JH, Lee SY, Kim JH, et al. Helicobacter pylori infection status and gastric tumor incidence according to the year of birth. Gut Liver. 2024; 18:457–464.

6. Lee SY. Comparison of gastric cancer screening strategies between Helicobacter pylori-infected,-eradicated, and-naive individuals. Korean J Helicobacter Up Gastrointest Res. 2022; 23:313–316.

7. Lee SY. Type A, type B, and non-atrophic gastritis. Korean J Helicobacter Up Gastrointest Res. 2023; 22:108–117.

8. Lee SY, Ahn YS, Moon HW. Comparison between the GastroPanel test and the serum pepsinogen assay interpreted with the ABC method: a prospective study. Helicobacter. 2024; 29:e13056.

9. Lee SY. Helicobacter pylori-negative gastric cancer. Korean J Helicobacter Up Gastrointest Res. 2020; 21:10–21.